Learn More
Combination of rituximab, bortezomib, doxorubicin, dexamethasone and chlorambucil (RiPAD1C) as first-line therapy for elderly mantle cell lymphoma patients: results of a phase II trial from the GOELAMS Background: There is no consensual first-line chemotherapy for elderly patients with mantle cell lymphoma (MCL). The GOELAMS (Groupe Ouest-Est des Leucé mies(More)
The efficacy and toxicity of combined paclitaxel and gemcitabine was evaluated in 54 chemotherapy-naive patients with metastatic non-small cell lung cancer (NSCLC). Gemcitabine i.v. 1000 mg/m(2)was administered on days 1 and 8 and paclitaxel 200 mg/m(2)as a continuous 3-hour infusion on day 1. Treatment was repeated every 21 days. Patients had a median age(More)
Solar photovoltaic (PV) deployment on existing building roof-tops has proven to be one of the most viable large scale resources of sustainable energy for urban areas. While there have been many studies on roof-top integrated PV systems at building and neighborhood scale, estimating the PV energy potential through the available roof surface area in large(More)
  • 1